Activity Overview
This Webcast contains video and downloadable slides from the symposium, Bridging Racial Disparities in Cancer Incidence and Outcomes, a prIME Oncology educational activity that was held on 30 July 2012 in New Orleans, Louisiana.
Topics
The challenge of disparities in medicine in the United States in 2012
David Satcher, MD, PhD
Overcoming disparities in cancer care: The role of the primary care team in cancer research
Worta McCaskill-Stevens, MD
Insights into racial disparities and breast cancer: A multifactorial challenge
William Gradishar, MD, FACP
Advances in the management of colorectal cancer
Edith Mitchell, MD, FACP
Prostate cancer: A rapidly evolving landscape
Michael A. Carducci, MD
Multiple myeloma for the primary care physician
Sagar Lonial, MD
Faculty
Chair
- Warren A. Jones, MD
University of Mississippi Medical Center
Jackson, Mississippi, United States
Faculty
- Michael Carducci, MD
Johns Hopkins University
Baltimore, Maryland, United States - William Gradishar, MD, FACP
Feinberg School of Medicine
Northwestern University
Chicago, Illinois, United States - Sagar Lonial, MD
Emory University
Atlanta, Georgia, United States - Worta McCaskill-Stevens, MD
National Cancer Institute
Bethesda, Maryland, United States - Edith Mitchell, MD, FACP
Thomas Jefferson University
Philadelphia, Pennsylvania, United States - David Satcher, MD, PhD
Morehouse School of Medicine
Atlanta, Georgia, United States
Target Audience
This educational activity is designed for healthcare professionals involved and/or interested in racial disparities in cancer incidence and outcomes.
Learning Objectives
After successful completion of this educational activity, participants should be able to:
- Examine racial disparities in cancer incidence and outcome, as well as the factors that contribute to these differences
- Evaluate recent data examining racial disparities in breast cancer, colorectal cancer, prostate cancer, and multiple myeloma
- Discuss potential diagnostic and therapeutic strategies to overcome racial disparities associated with breast cancer, colorectal cancer, prostate cancer, and multiple myeloma
Disclosures
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclosure of Conflicts of Interest
prIME Oncology assesses conflicts of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of activities. All relevant conflicts of interest that are identified are thoroughly vetted by prIME Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. prIME Oncology is committed to providing its learners with high-quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.
Disclosure Regarding Unlabeled Use
This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings.